Plexus Corp. (NASDAQ:PLXS) Insider Michael J. Running Sells 539 Shares

Plexus Corp. (NASDAQ:PLXS) insider Michael J. Running sold 539 shares of the company’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $155.87, for a total value of $84,013.93. Following the completion of the sale, the insider now owns 1,030 shares in the company, valued at $160,546.10. This represents a 34.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Plexus Stock Performance

Plexus stock opened at $162.01 on Friday. The stock’s 50-day moving average is $142.29 and its 200-day moving average is $123.67. The company has a market cap of $4.39 billion, a price-to-earnings ratio of 40.40 and a beta of 0.87. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.71. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $169.41.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. Plexus had a return on equity of 9.51% and a net margin of 2.82%. The business had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same quarter last year, the firm earned $1.44 earnings per share. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Equities analysts anticipate that Plexus Corp. will post 6.14 earnings per share for the current year.

Hedge Funds Weigh In On Plexus

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PLXS. Geode Capital Management LLC boosted its stake in Plexus by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 653,759 shares of the technology company’s stock valued at $89,392,000 after acquiring an additional 4,926 shares during the last quarter. Disciplined Growth Investors Inc. MN raised its stake in Plexus by 2.8% during the third quarter. Disciplined Growth Investors Inc. MN now owns 2,168,512 shares of the technology company’s stock valued at $296,457,000 after buying an additional 59,465 shares in the last quarter. Barclays PLC grew its position in shares of Plexus by 139.4% in the 3rd quarter. Barclays PLC now owns 48,786 shares of the technology company’s stock worth $6,669,000 after acquiring an additional 28,406 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Plexus during the 3rd quarter valued at approximately $286,000. Finally, Weiss Asset Management LP bought a new stake in Plexus during the third quarter valued at $2,580,000. 94.45% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on PLXS. StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Benchmark upped their price objective on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, October 28th. KeyCorp began coverage on Plexus in a research report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Finally, Needham & Company LLC increased their target price on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $133.50.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.